FDA catalyst calendar
Never miss a peptide FDA catalyst again.
PDUFA dates, AdCom meetings, Phase 3 readouts, and label expansions — one calendar, sourced from FDA.gov and sponsor filings.
Last updated:Jul 15, 2026Source:FDA.gov, sponsor IR, ClinicalTrials.govVerified:Manually reviewed by PeptidePlanet research teamData provider:PeptidePlanet Research
PDUFA & AdCom dates
The regulatory dates that move peptide biotech stocks, in one calendar.
Phase 3 readouts
Expected data disclosures tied to sponsor company and drug candidate.
Weekly brief
Subscribers get the upcoming week's catalyst list every Sunday evening.
Newsletter
Get the weekly PeptidePlanet brief.
Free weekly digest of peptide biotech catalysts, trial readouts, and FDA calendar events.
No spam. Unsubscribe anytime.
Frequently asked questions
- What is a PDUFA date?
- A PDUFA date is the FDA action date under the Prescription Drug User Fee Act — the deadline by which the FDA is expected to complete its review of a New Drug Application or Biologics License Application.
- What events show up on the catalyst calendar?
- PDUFA action dates, FDA Advisory Committee meetings, Phase 3 primary completion dates, expected data readouts, and material label-expansion decisions for peptide biotech.
- Where do the dates come from?
- FDA.gov, sponsor press releases, and ClinicalTrials.gov primary completion dates. Every catalyst on PeptidePlanet cites its source and includes a last-updated date.
- Is the calendar free?
- Yes — the FDA calendar is free to browse. Pro unlocks alerts, watchlist filtering, and the weekly catalyst brief.